TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)

​Recently, connected June 16, TD Cowen expert Josh Jennings maintained his Buy standing connected Boston Scientific Corporation (NYSE:BSX) with a terms people of $61. The expert noted that the steadfast remains assured successful the company's resilience contempt immoderate near-term pressures.

​The expert believes that Boston Scientific tin conscionable the little extremity of its fiscal Q2 2026 gross and EPS guidance. Moreover, the analysts noted that the expectations for the net person drifted down recently, which makes them progressively achievable. He acknowledges that definite areas person underperformed, peculiarly the US Watchman income and a fistful of different franchises. However, helium remains bullish overall, arsenic absorption continues to expect full integrated maturation to onshore wrong its targeted ranges for some Q2 and the afloat twelvemonth 2026.

Boston Scientific Corporation (NYSE:BSX) is simply a healthcare company,  incorporated successful 1979, that specializes successful aesculapian devices for interventional aesculapian specialties. The company's segments see MedSurg and Cardiovascular.

While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT:  10 Good Stocks to Invest successful Now and 10 Most Undervalued US Stocks According to Hedge Funds. 

Disclosure: None. Follow Insider Monkey connected Google News.